Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Pharmaceutical Research and Manufacturers of America (PhRMA). Prescription medicines: costs in context. Advocacy: Cost & Value of Medicines https://www.phrma.org/report/prescription-medicines-costs-in-context (2016).
Greenwood, J. U.S. drug costs must be weighed against benefits. Bloomberg News http://www.bloomberg.com/news/articles/2015-12-28/u-s-drug-costs-must-be-weighed-against-benefits (2015).
Scannell, J. W., Blanckley, A., Boldon, H. & Warrington, B. Nat. Rev. Drug Discov. 11, 191–200 (2012).
Brennan, Z. Congressmen investigate ‘shadow pricing’ of MS drugs. Regulatory Focus https://www.raps.org/regulatory-focus%E2%84%A2/news-articles/2017/8/congressmen-investigate-shadow-pricing-of-ms-drugs (2017).
Kelley, T. U.S. insulin prices rise as Sanofi, Novo await rivals. Bloomberg News https://www.bloomberg.com/news/articles/2013-08-15/u-s-insulin-prices-rise-as-sanofi-novo-await-rivals (2013).
Langreth, R. Hot drugs show sharp price hikes in shadow market. Bloomberg News https://www.bloomberg.com/news/articles/2015-05-06/diabetes-drugs-compete-with-prices-that-rise-in-lockstep (2015).
Barrett, P. & Langreth, R. The crazy math behind drug prices. Bloomberg Businessweek https://www.bloomberg.com/news/articles/2017-06-29/the-crazy-math-behind-drug-prices (2017).
Persistence Market Research. Biosimilar Market: Pricing Analysis 2006–2017 (Persistence Market Research, New York, 2017).
Hartung, D. M., Bourdette, D. N., Ahmed, S. M. & Whitham, R. H. Neurology 84, 2185–2192 (2015).
Benmeleh, Y. FDA deals blow to Teva’s defense plan with ruling on Bendeka. Bloomberg News http://www.bloomberg.com/news/articles/2016-03-29/fda-deals-blow-to-teva-s-defense-plan-with-ruling-on-bendeka (2016).
Serebrov, M. PBMs: The ‘shadow’ players in the drug pricing skirmish? BioWorld http://www.bioworld.com/content/pbms-shadow-players-drug-pricing-skirmish-0 (2016).
Tufts Center for the Study of Drug Development (CSDD). Cost of Developing a New Drug (Tufts CSDD, Boston, 2014).
Loftus, P. U.S. investigates drugmaker contracts with pharmacy-benefit managers. The Wall Street Journal https://www.wsj.com/articles/u-s-investigates-drugmaker-contracts-with-pharmacy-benefit-managers-1462895700 (2016).
Wingfield, N., Thomas, K. & Abelson, R. Amazon, Berkshire Hathaway and JPMorgan team up to try to disrupt health care. The New York Times https://www.nytimes.com/2018/01/30/technology/amazon-berkshire-hathaway-jpmorgan-health-care.html (2018).
The authors declare no competing interests.
About this article
Cite this article
Rathore, A.S., Shereef, F. Shadow pricing and the art of profiteering from outdated therapies. Nat Biotechnol 37, 217–220 (2019). https://doi.org/10.1038/s41587-019-0049-7
Policy Recommendations to Promote Prescription Drug Competition: A Position Paper From the American College of Physicians
Annals of Internal Medicine (2020)
Manufacturing biological medicines on demand: Safety and efficacy of granulocyte colony‐stimulating factor in a mouse model of total body irradiation
Biotechnology Progress (2020)